We are live on ! Find out more
VCIM

Velan Capital Investment Management Portfolio holdings

AUM $160M
1-Year Est. Return 517.12%
This Fund
S&P 500
This Quarter Est. Return
-4.19%
1 Year Est. Return
+517.12%
3 Year Est. Return
+2,524.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$124M
AUM Growth
+$16.3M
Cap. Flow
+$33.6M
Cap. Flow %
27.07%
Top 10 Hldgs %
77.75%
Holding
36
New
5
Increased
4
Reduced
4
Closed
7

Top Buys

Rank Stock Value
1
ALIM
Alimera Sciences
ALIM
+$39.5M
2
INSP icon
Inspire Medical Systems
INSP
+$3.86M
3
HRTX icon
Heron Therapeutics
HRTX
+$3.54M
4
GOSS icon
Gossamer Bio
GOSS
+$3.53M
5
APLS
Apellis Pharmaceuticals
APLS
+$2.2M

Top Sells

Rank Stock Value
1
ADMA icon
ADMA Biologics
ADMA
+$3.81M
2
GRTX
Galera Therapeutics, Inc. Common Stock
GRTX
+$3.12M
3
PNT
POINT Biopharma Global Inc. Common Stock
PNT
+$3.11M
4
CTLT
CATALENT, INC.
CTLT
+$2.17M
5
THC icon
Tenet Healthcare
THC
+$2.02M

Sector Composition

Rank Sector Weight
1 Healthcare 98.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALIM
1
DELISTED
Alimera Sciences
ALIM
$42.2M 34.02%
13,608,533
+11,948,879
+720% +$39.5M
PRAX icon
2
Praxis Precision Medicines
PRAX
$10.2B
$8.87M 7.15%
345,667
– –
JSPR icon
3
Jasper Therapeutics
JSPR
$26.6M
$7.59M 6.12%
1,121,904
– –
HRTX icon
4
Heron Therapeutics
HRTX
$63.4M
$7.2M 5.8%
6,986,744
+2,486,744
+55% +$3.54M
ADMA icon
5
ADMA Biologics
ADMA
$2.18B
$6.22M 5.01%
1,736,100
-989,951
-36% -$3.81M
TELA icon
6
TELA Bio
TELA
$41.6M
$5.97M 4.81%
746,087
– –
QIPT
7
DELISTED
Quipt Home Medical
QIPT
$5.6M 4.52%
1,100,000
+130,000
+13% +$697K
LNTH icon
8
Lantheus
LNTH
$6.59B
$5.21M 4.2%
75,000
-25,000
-25% -$1.83M
OPTN
9
DELISTED
OptiNose
OPTN
$4.42M 3.57%
239,791
– –
MLTX icon
10
MoonLake Immunotherapeutics
MLTX
$1.47B
$3.15M 2.54%
55,300
– –
INSP icon
11
Inspire Medical Systems
INSP
$1.73B
$3.04M 2.45%
+15,300
New +$3.86M
IMGN
12
DELISTED
Immunogen Inc
IMGN
$3.01M 2.43%
189,500
– –
NSPR icon
13
InspireMD
NSPR
$37.5M
$2.96M 2.38%
904,029
– –
GOSS icon
14
Gossamer Bio
GOSS
$86.1M
$2.55M 2.06%
+3,065,136
New +$3.53M
CABA icon
15
Cabaletta Bio
CABA
$457M
$2.28M 1.84%
150,000
-100,000
-40% -$1.37M
APLS
16
DELISTED
Apellis Pharmaceuticals
APLS
$1.9M 1.53%
+50,000
New +$2.2M
GERN icon
17
Geron
GERN
$949M
$1.65M 1.33%
778,500
– –
THC icon
18
Tenet Healthcare
THC
$20.9B
$1.64M 1.33%
24,937
-26,963
-52% -$2.02M
ICVX
19
DELISTED
Icosavax, Inc. Common Stock
ICVX
$1.24M 1%
160,630
– –
ASLN
20
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$1.18M 0.95%
+78,125
New +$1.43M
IOVA icon
21
CALL
Iovance Biotherapeutics
IOVA
$2.9B
$1.14M 0.92%
+250,000
New +$1.63M
ANNX icon
22
Annexon
ANNX
$883M
$1.09M 0.88%
459,746
– –
EDSA icon
23
Edesa Biotech
EDSA
$50.5M
$810K 0.65%
183,088
– –
CGEM icon
24
Cullinan Oncology
CGEM
$1.18B
$679K 0.55%
75,000
+25,000
+50% +$260K
IFRX icon
25
InflaRx
IFRX
$289M
$596K 0.48%
200,000
– –
1
2

Similar funds

BFAG
Blackston Financial Advisory Group The Villages, Florida $160M AUM 16.38% 1-Year Est. Return
SLG
Sanchez Levi Garrett $159M AUM
SMF
Sterling Manor Financial Saratoga Springs, New York $160M AUM 13.84% 1-Year Est. Return
LCA
Legend Capital Advisors New York $160M AUM
SA
swisspartners Advisors Zurich, Switzerland $159M AUM 36.51% 1-Year Est. Return
SGCM
Sanchez Gaunt Capital Management Reno, Nevada $160M AUM
RP
RIHO Partners Tucson, Arizona $159M AUM
PCC
Perry Creek Capital New York $160M AUM 3.05% 1-Year Est. Return

Velan Capital Investment Management's Q3 2023 Portfolio in Review

As of Q3 2023, Velan Capital Investment Management held 36 positions worth $124M, up 15% from $108M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Velan Capital Investment Management deployed $33.6M of net new capital in Q3 2023, opening 5 new positions and adding to 4 existing holdings. Its largest new stake was Inspire Medical Systems: 15,300 shares worth $3.04M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 99% a quarter earlier.

On the sell side, the largest reduction was ADMA Biologics, an estimated $3.81M trimmed.

  • Velan Capital Investment Management's largest Q3 2023 buy was Inspire Medical Systems: 15,300 shares worth $3.04M.
  • Velan Capital Investment Management added most to Alimera Sciences in Q3 2023, an estimated $39.5M increase.
  • Velan Capital Investment Management's biggest Q3 2023 reduction was ADMA Biologics, cutting an estimated $3.81M.
  • Velan Capital Investment Management fully exited Galera Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $3.12M.
  • Velan Capital Investment Management's ten largest holdings make up 78% of its $124M portfolio in Q3 2023.
  • Velan Capital Investment Management opened 5 new positions and closed 7 in Q3 2023.
  • Velan Capital Investment Management's portfolio value rose 15% quarter-over-quarter to $124M.

Based on Velan Capital Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.